Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;63(8):1325-31.
doi: 10.1002/pbc.26021. Epub 2016 Apr 15.

Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review

Chris A Rees  1 , Elizabeth M Keating  1 , Heather Lukolyo  1 , Heather E Danysh  1   2 , Michael E Scheurer  1   2 , Parth S Mehta  1   2 , Joseph Lubega  1   2 , Jeremy S Slone  1   2 ; Baylor Pediatric HIV-Related Malignancy Consortium
Affiliations
Review

Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review

Chris A Rees et al. Pediatr Blood Cancer. 2016 Aug.

Abstract

Children with human immunodeficiency virus (HIV) have an increased risk of developing Kaposi Sarcoma (KS) and non-Hodgkin lymphoma (NHL) compared to HIV-negative children. We compiled currently published epidemiologic data on KS and NHL among children in sub-Saharan Africa (SSA). Among countries with available data, the median incidence of KS was 2.05/100,000 in the general pediatric population and 67.35/100,000 among HIV-infected children. The median incidence of NHL was 1.98/100,000 among the general pediatric population, while data on NHL incidence among HIV-infected children were lacking. Larger regional studies are needed to better address the dearth of epidemiologic information on pediatric KS and NHL in SSA.

Keywords: Africa; Kaposi sarcoma; epidemiology; non-Hodgkin lymphoma; pediatric.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest statement: the authors have no conflicts of interest.

Figures

Figure 1.
Figure 1.
Pediatric Kaposi Sarcoma (KS) incidence (A) and prevalence (B) in sub-Saharan Africa as reported in this review. The size of the symbol indicates the relative size of the estimate, with smaller symbols representing lower relative incidence or prevalence and larger symbols representing higher relative incidence or prevalence. The KS incidence in panel A ranges from 0.03[35] to 160 per 100,000[24]. The KS prevalence in panel B ranges from 0.04[25] to 3,200 per 100,000[36].
Figure 2.
Figure 2.
Pediatric Non-Hodgkin Lymphoma (NHL) incidence (A) and prevalence (B) in sub-Saharan Africa as reported in the literature reviewed. The size of the symbol indicates the relative size of the estimate, with smaller symbols representing lower relative incidence or prevalence and larger symbols representing higher relative incidence or prevalence. The NHL incidence in panel A ranges from 0.17[43] to 6.79 per 100,000[28]. The NHL prevalence in panel B ranges from 7.1[25] to 155 per 100,000[37].
See this image and copyright information in PMC

References

    1. Kaatsch P Epidemiology of childhood cancer. Cancer Treat Rev 2010;36:277–285. - PubMed
    1. Stack M, Walsh PM, Comber H, Ryan CA, O’Lorcain P. Childhood cancer in Ireland: a population-based study. Arch Dis Child 2007;92:890–897. - PMC - PubMed
    1. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT; Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 2008;148:728–736. - PubMed
    1. Alvaro-Meca A, Micheloud D, Jensen J, Diaz A, Garcia-Alvarez M, Resino S. Epidemiologic trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008. Pediatr Infect Dis J 2011;30:764–768. - PubMed
    1. Ribeiro RC, Steliarova-Foucher E, Magrath I, Lemerle J, Eden T, Forget C, Mortara I, Tabah-Fisch I, Divino JJ, Miklavec T, Howard SC, Cavalli F. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008;9:721–729. - PMC - PubMed